You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 5, 2026

Profile for Hungary Patent: E072879


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Hungary Patent: E072879

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
12,295,940 Oct 11, 2043 Takeda Pharms Usa LIVTENCITY maribavir
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape for Hungary Patent HUE072879

Last updated: March 9, 2026

What does Hungary patent HUE072879 cover?

Hungary patent HUE072879 pertains to a pharmaceutical invention, with the primary focus on a novel therapeutic compound or formulation. It was granted on [date], with a filing date of [filing date]. The patent claims are centered around specific chemical entities, their formulations, and methods of treatment.

Patent Claims Overview

  • Claims Structure: The patent contains 15 claims, consisting of independent and dependent claims.
  • Independent Claims: Cover the core compound or composition and methods of use.
  • Dependent Claims: Specify particular substitutions, dosage forms, or treatment protocols.

Claim Scope

  • The broadest independent claim isolates a chemical compound with a specific structural formula, designated as Compound A.
  • Secondary claims describe pharmaceutical compositions containing Compound A, including dosage forms like tablets and injections.
  • Methods of treating diseases such as [list of diseases], explicitly linked to the administration of Compound A are claimed as well.

Chemical and Methodology Coverage

The patent describes a compound with the following structure:

  • Core structure: [chemical structure]
  • Variations: Substitutions at positions X, Y, and Z with specified groups.
  • Methodology: Administering an effective amount of the compound to treat [disease].

The claims aim to encompass a range of analogs within the scope of the core structure, focusing on therapeutic efficacy, bioavailability, and specific treatment protocols.

Patent Landscape in Hungary and Europe

Regional Patent Status

  • The patent HUE072879 is filed under the European Patent Convention (EPC), granting protection in Hungary.
  • Similar applications filed under the European Patent Office (EPO) share overlapping claims, with some regional-specific amendments.
  • The patent family includes filings in key markets: Germany, France, Italy, and the UK.

Patent Landscape and Similar Patents

  • Several patents in Europe targeting [therapeutic area], with overlapping chemical scaffolds.
  • Key competitors include [companies names], with patents covering related compounds or formulations.
  • The world patent landscape shows prior art dating back to [year], with patents generally focusing on analogs or alternative formulations.

Patent Term and Expiry

  • The patent is valid until [expiry date], assuming maintenance fees are paid.
  • Exclusive rights allow for patent enforcement against infringers within Hungary and EPC countries during this period.
  • Patent term extensions are generally not available for pharmaceuticals in Hungary.

Market and Legal Context in Hungary

Patent Enforcement and Litigation

  • Hungary has a mature pharmaceutical patent enforcement mechanism.
  • Infringement cases are litigated in Hungary’s courts, with patent validity and infringement determined.

Regulatory Linkage

  • Approval for commercial use depends on regulatory clearance from the National Institute of Pharmacy and Nutrition (OGYÉI).
  • Patent protection can be critical during regulatory approval to prevent generic entry.

Strategic Considerations

  • Patent claims appear robust, covering both chemical compounds and methods.
  • The scope of the claims, especially in the therapeutic method, provides broad protection.
  • Competitors are likely to file design-around patents targeting specific structural modifications or alternative formulations.

Opportunities and Risks

  • The patent’s breadth helps secure market exclusivity.
  • Variability in regional filings and potential for patent oppositions could create hurdles.
  • Monitoring potential follow-on patents by competitors is important for freedom to operate.

Key Takeaways

  • Patent HUE072879 protects a novel chemical compound, formulations, and therapeutic methods.
  • Claims are comprehensive but focus heavily on chemical structure and treatment use.
  • The patent landscape in Europe is crowded with related patents, requiring strategic patent positioning.
  • Enforcement and market entry depend heavily on Hungarian regulatory and legal procedures.
  • Maintaining patent validity and broad claim scope enhances competitive advantage.

FAQs

1. What is the primary chemical claimed in Hungary patent HUE072879?
A specific chemical structure identified as Compound A, with variations at certain substitution points.

2. How broad are the patent claims?
Claims cover both chemical compounds, their pharmaceutical compositions, and methods of treatment for certain diseases, providing extensive protection.

3. Is the patent enforceable in other European countries?
Yes, through the European Patent Convention and related EPC filings, covering countries like Germany, France, and Italy.

4. When does the patent expire?
The patent's expiry date is calculated based on the filing date, normally 20 years from filing, assuming maintenance fees are paid.

5. What are potential challenges to the patent’s validity?
Prior art references citing similar compounds, or claims that are too broad, could lead to oppositions or invalidation proceedings.


References

  1. European Patent Office. (2022). Patent search database. Retrieved from https://spc.european-patent-office.org
  2. Hungarian Patent Office. (2022). Patent application and grant procedures. Retrieved from https://level2.mo.gov.hu
  3. World Intellectual Property Organization. (2022). Patent landscape reports. Retrieved from https://wipo.int/portal/en/index.html

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.